Tumor suppressor protein p53 plays a crucial role in maintaining genomic integrity in response to DNA damage. Regulation of translation of p53 mRNA is a major mode of regulation of p53 expression under genotoxic stress. The AU/U-rich element-binding protein HuR has been shown to bind to p53 mRNA 3 0 UTR and enhance translation in response to DNA-damaging UVC radiation. On the other hand, the microRNA miR-125b is reported to repress p53 expression and stress-induced apoptosis. Here, we show that UVC radiation causes an increase in miR-125b level in a biphasic manner, as well as nuclear cytoplasmic translocation of HuR. Binding of HuR to the p53 mRNA 3 0 UTR, especially at a site adjacent to the miR-125b target site, causes dissociation of the p53 mRNA from the RNA-induced silencing complex (RISC) and inhibits the miR-125b-mediated translation repression of p53. HuR prevents the oncogenic effect of miR125b by reversing the decrease in apoptosis and increase in cell proliferation caused by the overexpression of miR-125b. The antagonistic interplay between miR-125b and HuR might play an important role in fine-tuning p53 gene expression at the post-transcriptional level, and thereby regulate the cellular response to genotoxic stress.
Introduction
The tumor suppressor protein p53 plays a crucial role in maintaining genomic integrity by governing cell-cycle progression, DNA repair and apoptosis in response to genotoxic stress. 1 On exposure to stress stimuli such as DNA damage, hypoxia or nutrient deprivation, p53 is mostly activated through posttranslational modifications and altered subcellular localization, resulting in increased protein stability and activity. 2 However, increasing evidence has shown that p53 expression is also controlled by the regulation of p53 mRNA stability and translation. 3 Both RNA-binding proteins (RBPs) and non-coding RNAs (ncRNAs) have been implicated in such regulation. 4 RBPs Ribosomal protein (RPL26), poly-pyrimidine tract binding protein (PTB) and nucleolin are reported to bind to the 5 0 -untranslated region (5 0 -UTR) of p53 mRNA and regulate capdependent and Internal Ribosome Entry site (IRES)-mediated translation. 5, 6 Similarly, Wig1 and HuR bind to the 3 0 -untranslated region (3 0 UTR) of p53 mRNA and enhance mRNA stability and translation. [7] [8] [9] HuR is an RBP belonging to the Hu/ ELAV (embryonic lethal abnormal vision) family of RBPs which interacts with AU-and U-rich elements mostly present in the 3 0 UTR of target mRNAs to regulate stability and/or translation. 10 HuR has been shown to bind to the p53 mRNA 3 0 UTR and enhance p53 translation in response to ultraviolet C (UVC) radiation. 8 It has been suggested that translation regulation of p53 by HuR in response to genotoxic stress allows the synthesis of p53 protein while cellular transcription is paused during a period of DNA repair. p53 translation is also negatively regulated by 2 miRNAs, miR-125a and miR-125b, which target the same miRNA response element in the p53 mRNA 3 0 UTR. 11, 12 miR-125b has been shown to be an important negative regulator of p53 protein synthesis, and p53-mediated apoptosis, during stress response in human cells and development of zebrafish embryos.
12 miR-125b is reported to act as a tumor suppressor in some cancers but as an oncogene in other cancer types. 13 Negative regulation of p53 translation by miR-125b might be an important determinant of the latter's oncogenic activity.
While RBPs and miRNAs are known to independently regulate the stability and/or translation of specific mRNAs, a number of recent reports have demonstrated functional interplay between specific RBPs and miRNAs in regulating translation of multiple genes. 14 This interplay can either be antagonistic, where the binding of the RBP prevents the binding of the miRNA, such as in the case of HuR preventing the translation repression of the CAT1 mRNA by miR-122 during amino acid starvation or DND1 alleviating the miR-221 and miR-222-mediated repression of cyclin-dependent kinase inhibitor 1B (CDKN1B). 15, 16 It can also be cooperative, such as in the case of the RBP tristetraprolin (TTP) enabling the miR-16-mediated translation repression of tumor necrosis factor (TNFa) and cycloxygenase 2 (COX2) mRNAs. 17 Interplay between RBPs and miRNAs appear to be an important mode of fine-tuning gene expression in various cellular processes, especially cancer. Recently, a long non-coding RNA, 7SL, was found to repress p53 translation by competing with HuR, but no such interplay between miRNAs and RBPs in regulating p53 mRNA translation is known. 18 In this study we have shown the antagonistic interplay between HuR and miR-125b in regulating p53 mRNA translation under genotoxic stress. Binding of HuR to the p53 mRNA 3 0 UTR prevented miR-125b mediated translation repression, and counteracted the cell growth-promoting and anti-apoptotic activity of miR-125b. UVC irradiation caused nuclear-cytoplasmic translocation of HuR, which interacted with the p53 mRNA 3 0 UTR, allowing high level of p53 expression. HuR-mediated de-repression of p53 translation might therefore be a means of maintaining p53 level in presence of high concentration of miR-125b under genotoxic stress.
Results
HuR reverses miR-125b-mediated repression of p53 mRNA translation Three sequences within the p53 3 0 UTR have been reported to be potential HuR binding sites (Fig. 1A) . One, an U-rich sequence, is present exactly adjacent to the miR-125b binding site, and is predicted to form an independent single-stranded region by the Mfold RNA folding program (Fig. S1 ) suggesting that HuR binding might influence miR-125b mediated translation repression of p53. Overexpression of miR-125b inhibited p53 expression in MCF7 human breast carcinoma cells in a dose-dependent manner (Fig. 1B) . However, exogenous expression of HuR in presence of the highest concentration of miR-125b, reversed the inhibition of p53 expression and restored p53 expression to near normal level. Overexpression of HuR alone caused a moderate increase in p53 expression (Fig. 1C) . However, there was no significant change in p53 mRNA level either on miR-125b or HuR overexpression, indicating that HuR reversed the miR-125b-mediated translation repression of p53 mRNA without affecting the mRNA level (Fig. S2A) . Also, overexpression of HuR did not reduce miR-125b level, suggesting that the effect of HuR was not mediated by the degradation or inhibition of synthesis of the miRNA (Fig. S2B) . In order to check whether the effect of HuR was mediated via the p53 3 0 UTR, miR-125b was coexpressed with a reporter gene construct consisting of the p53 3 0 UTR inserted downstream of firefly luciferase gene. miR-125b overexpression showed a dose-dependent decrease in luciferase activity, which was rescued by overexpression of HuR, whereas no effect was observed on a firefly reporter construct lacking the p53 3 0 UTR (Fig. 1D) . We also investigated whether interaction with HuR could dissociate the p53 mRNA from the RISC complex. p53 mRNA was found to be associated with Ago2 by RNA-immunoprecipitation of lysates from cells expressing miR-125b (Fig. 1E) . Conversely, HuR overexpression, even in presence of miR-125b, resulted in significantly enhanced association of p53 mRNA with HuR, suggesting that HuR binding could dissociate the p53 mRNA from the RISC complex. In order to confirm whether HuR reversed the translation repression of p53 mRNA by miR-125b, ribosomal fractionation was performed with cells overexpressing miR-125b, and miR-125b together with HuR. Analysis of the ribosomal fractions showed that p53 mRNA was mostly present in the non-translating and lighter polysomal fractions of the cells expressing miR-125b compared to the control cells, in which it was mostly associated with the heavier polysomal fractions (Fig. 1F and quantitation) . However, overexpression of HuR caused the shifting of p53 mRNA to the heavier polysomal fractions, showing that HuR could reverse the translation repression of p53 caused by miR125b. Overexpression of HuR alone also caused association of p53 mRNA with heavy polysomes, supporting the role of HuR in enhancing p53 mRNA translation.
UVC irradiation causes nuclear-cytoplasmic translocation of HuR and prevents miR-125b-mediated translation repression of p53 UVC-induced DNA damage is known as a potent stimulus for translational upregulation of p53. 8 Exposure of MCF7 breast carcinoma cells to a 10 J/m 2 pulse of UVC radiation, followed by monitoring p53 protein level in the cytoplasm over a period of 12 hours, showed an increase of p53 from 2 hour onwards, reaching a maximum at around 4 hours and then decreasing to near-basal level by 12 hours post-UVC exposure ( Fig. 2A) . Interestingly, miR-125b expression showed a 90% decrease at 2 hour post-UVC exposure and then gradually increased by more than 10-fold in the next 10 hours (Fig. 2B) . In order to validate whether the decreased p53 level at 8-12 hours post UVC-exposure was due to the increase in miR-125b, cells were transfected with an antisense oligo to miR-125b (miR-125b antagomiR) prior to UVC exposure. Cells transfected with miR-125b antagomiR showed increased p53 expression at 8-12 hours post UVC exposure, suggesting that the decrease in p53 level was due to high levels of miR-125b (Fig. S3) . The increased level of p53 at 2 hour post UVC exposure might therefore be due to the large decrease of miR-125b at this time point. However, as p53 level was high at 4-6 hours post UVC exposure in presence of increased miR-125b, we checked whether HuR contributed to this upregulation of p53 protein by preventing miR-125b-mediated translation repression. Cytoplasmic HuR level showed a similar pattern as p53, increasing from 2 hour post UVC irradiation, reaching a maximum at 4 hours and subsequently decreasing, coinciding with the decrease in the p53 level (Fig. 2C) . RNA immunoprecipitation using anti-HuR antibody, followed by semiquantitative RT-PCR using p53-specific primers, showed enhanced association of p53 mRNA with HuR protein at 4 hour post-UVC treatment, which decreased at 12 hour (Fig. 2D) . Immunofluorescence of UVC-irradiated cells using HuR-specific antibody showed nuclear-cytoplasmic RNA associated with the immunoprecipitates was subjected to qRT-PCR using p53 and GAPDH primers, and p53 mRNA levels were normalized to GAPDH mRNA levels. (F) Ribosomal fractions from MCF7 cells, either mock transfected or transfected with pSUPER-miR-125b or pSUPER-miR-125b and pCI-neo-myc-HuR, or with pCI-neo-mycHuR alone were analyzed by sucrose density gradient fractionation. rRNA content, measured at 254 nm, is plotted against fraction numbers. RNA isolated from selected fractions was analyzed by semi-quantative RT-PCR using p53 and GAPDH primers. The level of mRNA content in each fraction, represented as band intensity of PCR products of each lane as % of total band intensity of all lanes, are plotted against respective fraction numbers below. translocation of HuR from 2 hours post-UVC exposure, reaching a maximum cytoplasmic level at 4 hours and subsequently decreasing, suggesting that the UVC-induced cytoplasmic translocation of HuR allowed its specific interaction with the p53 mRNA, and corresponded with high level of p53 expression, even in the presence of enhanced miR-125b (Fig. 2E) . Fractionation of the UVC-irradiated cells into nuclear and cytosolic fractions, followed by immunoblotting for HuR, also showed the gradual nuclear-cytoplasmic translocation of HuR, reaching a maximum cytosolic level at around 4-6 hours, and subsequently decreasing by 12 hours post UVC exposure (Fig. 2F) .
HuR causes the UVC-mediated enhancement of p53 mRNA translation by competing with miR-125b
In order to confirm that the enhancement of p53 post UVC irradiation was at least in part due to HuR, MCF7 cells were RNA associated with the immunoprecipitate was subjected to RT-PCR using p53 or GAPDH primers. Input represents total RNA isolated from cell lysate. (E) MCF7 cells were UVC treated and immunofluorescence of cells collected at various time points post UVC treatment was observed using anti-HuR primary and AlexaFluor568-conjugated secondary antibodies (red). Nucleus was visualized using DAPI staining (blue). (F) MCF7 cells were UVC irradiated following which cells collected at various time points were fractionated into nuclear and cytoplasmic fractions. Fractions were immunoblotted with anti-HuR, anti-lamin (nuclear marker) and anti-b actin (cytoplasmic marker) antibodies.
transfected with siRNA against HuR and control siRNA, in presence and absence of UVC irradiation (Fig. 3A) . In absence of UVC irradiation, siRNA against HuR efficiently knocked down HuR level, together with a decrease in p53 level, compared to cells treated with the control siRNA (left panel). However, on UVC irradiation, cells treated with the control siRNA showed an increase in HuR level after 4 hours, with a subsequent decrease at 12 h as observed earlier. HuR level remained uniformly low in presence of siRNA against HuR. p53 protein level also showed an increase at 4 hours in control siRNA-treated cells followed with a decrease at 12 hours upon UVC exposure, but in cells treated with HuR siRNA, p53 level remained unchanged (right panel). Together these observations indicate that HuR is responsible for enhanced expression of p53 post UVC exposure. In order to investigate whether HuR prevented the loading of the RISC complex on the p53 mRNA post UVC exposure, RNA immunoprecipitation using HuR and Ago2 antibodies was done from cells which have been transfected with HuR siRNA or control siRNA prior to UVC irradiation (Fig. 3B) . In cells transfected with control siRNA, p53 mRNA was found to be associated with HuR at 4 h post UVC irradiation, when HuR is mostly present in the cytoplasm. However at 12 h post UVC exposure, when HuR level is low and miR-125b level is high, p53 mRNA was mostly associated with Ago2. Conversely, in cells transfected with HuR siRNA, p53 mRNA was always associated with Ago2, with maximum association at 12 h when miR-125b is expressed at the highest level, suggesting that in absence of HuR, miR-125b is efficiently loaded on p53 mRNA post UVC exposure. This was further verified by RNA immunoprecipitation from cells transfected with an antagomiR against miR-125b, and a control oligonucleotide, prior to UVC exposure (Fig. 3C) . In cells transfected with the control oligo, p53 mRNA was found to be mostly associated with HuR at 4 h post UVC irradiation and with Ago2 at 12 h post UVC irradiation. However, in cells transfected with the miR-125b antagomiR, p53 mRNA was associated with HuR at 4 h post UVC exposure, but not associated with Ago2 at 12 h post UVC exposure, showing that the RISC complex is not loaded on the p53 mRNA post UV irradiation if miR-125b is antagonized, even when HuR level is low. These observations were further supported by RNA immunoprecipitation from cells in which miR125b was overexpressed prior to UVC exposure (Fig. 3D) . In control cells, p53 mRNA was mostly associated with HuR at 4 h and with Ago2 at 12 h post UV exposure. However, in cells overexpressing miR-125b, there was high association with Ago2 at all time points post UVC exposure, with nearly equal binding of p53 mRNA with HuR and Ago2 at 4 h post UV exposure, when cytoplasmic HuR level is high. Together, these observations show that HuR is responsible for the UVC-mediated enhancement of p53 translation by competing with miR125b-RISC binding to the p53 mRNA.
The binding site of HuR proximal to the miR-125b target site is necessary and sufficient for preventing translation repression A PAR-CLIP experiment to detect transcriptome-wide binding sites for HuR had suggested 3 binding sites for HuR in p53 mRNA 3 0 UTR. 19 The first site, a U-rich sequence, is adjacent to the miR-125b binding site whereas the other 2 sites are located more distally. We have referred to the 3 sites as proximal (P), middle (M) and distal (D) (Fig. 4A and Fig. S1 ). In order to determine the contribution of the 3 potential HuR-binding sites to HuR binding and reversal of miR-125b-mediated translation repression, we have deleted the 3 binding sites singly or in combination, and evaluated the binding to purified HuR. Deletion of any of the 3 sites resulted in decreased HuR binding, with the maximum decrease observed in case of removal of the P site and the minimum decrease seen on removal of the M site (Fig. 4B) . Deletion of both the P and D sites resulted in further decrease of HuR binding whereas removal of all the 3 sites resulted in near abrogation of HuR binding. We also (Fig. S4) .
In order to evaluate the contribution of the HuR binding sites to the rescue of miR-125b mediated translation repression induced by HuR, we made reporter gene constructs containing deletion fragments of the p53 3 0 UTR lacking each of the 3 binding sites. Reporter gene assay following cotransfection with miR-125b and HuR expressing constructs showed that absence of the P site resulted in failure of rescue of miR-125b-mediated translation repression (Fig. 4C) . Lack of the D site resulted in partial rescue of translation repression, although the restoration of reporter gene activity was greater than that in the case of absence of the P site. Removal of the M site did not affect the rescue of translation by HuR. Removal of both P and D sites, or all the 3 sites, resulted in failure of rescue of translation. Finally, the construct containing the 200 nucleotide fragment consisting of the miR-125b binding site and only the P site was able to completely restore translation on HuR overexpresion. Together, these observations suggest that the proximal HuR binding site is necessary and sufficient for the reversal of miR-125b-mediated translation repression by HuR.
HuR reverses the anti-apoptotic and cell proliferative effect of miR-125b miR-125b has been shown to regulate both apoptosis and cell proliferation in various cellular contexts. 13 Specifically, miR125b has been shown to suppress p53-induced apoptosis. 12 Therefore we investigated in what way the antagonistic relationship between miR-125b and HuR in regulating p53 expression affects proliferation and apoptosis of cells. MCF7 cells overexpressing miR-125b, when subjected to serum deprivation, an apoptotic stimulus, showed reduced level of apoptosis (4%) compared to mock transfected cells (33%) as observed by Annexin-V-FITC and PI staining (Fig. 5A) . However, on coexpression of HuR, the proportion of apoptotic cells increased to 37%, indicating that HuR could reverse the suppression of apoptosis induced by miR-125b. Expression of HuR alone moderately increased the proportion of apoptotic cells (Fig. S5) . Comparison of proliferation rates of the mock-transfected and miR-125b-overexpressing cells over a 72 hour period showed a significantly higher rate of proliferation of the miR125b-expressing cells (Fig. 5B) . Overexpression of HuR in the miR-125b-expressing cells reduced the proliferation rate to that of mock-transfected cells. Overexpression of HuR alone did not cause a change in rate of cell proliferation compared to mocktransfected cells. Exposure of miR-125b-expressing cells to UVC irradiation also reduced the cell proliferation rate to that of mock-transfected cells (Fig. 5C ). The effect of HuR in the UVC-induced reversal of cell proliferation was investigated by exposing miR-125b-expressing cells transfected with siRNA against HuR to UVC, in which case the cell proliferation rate increased significantly. This indicated that the reduction in the proliferation rate of miR-125b-expressing cells on UVC exposure was mediated by HuR. siRNA-mediated knockdown of HuR, both in absence and presence of UVC irradiation, also caused significant increase in cell proliferation, suggesting an important role of HuR in controlling the proliferative potential of cells.
Evaluation of colony forming potential showed significantly increased colony formation by the miR-125b-overexpressing cells, which was reduced by HuR overexpression as well as by UVC-irradiation (Fig. 5D, left and right panels) . HuR overexpression or UVC irradiation only also caused reduction in colony formation compared to mock transfected cells (Fig. S6) . Together, these observations showed that miR-125b overexpression can reduce apoptosis and enhance cell proliferation and colony formation in MCF7 cells, which can be reversed by HuR overexpression or UVC-irradiation.
The antagonistic effect of HuR and miR-125b on cell proliferation and apoptosis is mediated via p53
HuR and miR-125b were found to exert opposing effects on the tumorigenic potential of cells, with miR-125b expression enhancing cell proliferation and reducing apoptosis, and HuR expression reversing the above effects of miR-125b. As HuR and miR-125b were shown to act antagonistically in regulating p53 expression, we therefore investigated whether the opposing effects of HuR and miR-125b in the process of oncogenesis is mediated via p53. Cells transfected with a non-specific siRNA together with the miR-125b-expressing construct, when subjected to an apoptotic stimuli, showed a reduced proportion of apoptotic cells (17%) compared to cells only transfected with the non-specific siRNA (24%) (Fig. 6A) . The percentage of apoptotic cells was enhanced when HuR was overexpressed alone (39%), or together with miR-125b (46%) or when miR-125b expressing cells were exposed to UVC (27%). Cells transfected with a siRNA against p53 showed a much reduced level of apoptosis (4%) which remained nearly unchanged when subjected to miR-125b or HuR overexpression, or on UVC irradiation. This indicated that the effects of miR-125b and HuR on cellular apoptosis are mediated via p53. Comparison of proliferation rates of control siRNA and p53 siRNA transfected cells, subjected to miR-125b or HuR overexpression or both, over a 72 hour period also showed that the effects of miR-125b and HuR on cell proliferation was mediated by p53 (Fig. 6B) . miR125b enhanced cell proliferation in control siRNA-transfected cells, but failed to do so in cells transfected with p53 siRNA.
The proliferation rate of p53 siRNA-transfected cells was significantly higher than that of control siRNA-transfected cells, and was refractory to either miR-125b or HuR expression or both, as well as to UV irradiation. Evaluation of colony forming potential of control siRNA and p53 siRNA transfected cells showed that knockdown of p53 significantly enhanced the colony formation by cells (Fig. 6C, right and left panels) . However, remarkably, when miR-125b was overexpressed in the cells in which p53 has been knocked down, the colony numbers decreased compared to control siRNA-transfected cells in which miR-125b was overexpressed. The reduction in colony formation by miR-125b overexpression in p53 knocked down cells was not reversed by HuR overexpression or UVC irradiation. This points to the possibility that the cell proliferative effects of miR-125b is mediated by its translation repressive effect on p53 and when p53 is silenced over a prolonged period, the antiproliferative effect of miR-125b becomes dominant. Similarly, HuR overexpression in p53 knocked down cells also showed enhanced colony formation, suggesting that the prooncogenic function of HuR dominates in absence of p53.
Discussion
The response of p53 to genotoxic stress is crucial for maintaining the integrity of the genome by causing cell cycle arrest, while allowing for the repair of damaged DNA and ultimately causing programmed cell death if the DNA damage is too severe to be repaired. 2 Although post-translational modification and protein stabilization play a major role in the upregulation of p53 protein in response to genotoxic stress, a substantial number of studies have suggested a critical role for the enhanced translation of p53 mRNA after DNA damage. 5, 6, 20, 21 It has been suggested that stimulation of translation of specific genes, such as p53, in response to DNA damage would allow transcription to pause while DNA repair can proceed so as to prevent aberrant transcripts from being generated but permitting the synthesis of proteins specifically required for the genotoxic stress response. 8 We have now demonstrated that this enhanced translation of p53 in response to UVC irradiation is, at least in part, mediated by HuR preventing the translation repression of p53 by the UVC-induced miRNA, miR-125b.
miR-125b, a miRNA belonging to the miR-125a/b family in vertebrates and homologous to lin-4 in C. elegans, is a known negative regulator of p53. 12 Overexpression of miR-125b has been shown to reduce p53 level, and suppress apoptosis, in human neuroblastoma and lung fibroblast cells. Interestingly, miR-125b was found to be downregulated when zebrafish embryos were treated with DNA-damaging agents, which corresponded to the rapid increase in p53 protein level in response to DNA damage. 12 Remarkably, in our study we found a biphasic pattern of miR-125b expression in response to UVC irradiation, with miR-125b level initially decreasing after UVC exposure following which there was a substantial increase over the next 10 hours. The initial decrease in miR-125b level corresponded to an increase in p53 protein. However, subsequently when miR-125b level again increased, p53 mRNA was protected from translation repression by HuR, which was found to interact with the p53 mRNA and cause its dissociation from the RISC complex. This function of HuR appears to reverse the decrease in apoptosis and increase in cell proliferation induced by miR-125b. miR-125b has been shown to regulate both cell proliferation and apoptosis, in a cellular context-dependent manner and can potentially act as both a tumor suppressor and an oncogene. 13 miR-125b expression is down-regulated in ovarian and thyroid cancers 22, 23 but upregulated in pancreatic cancer, prostate cancer, megakaryoblastic leukemia and acute myeloid leukemia (AML). [24] [25] [26] [27] [28] Although miR-125b downregulates apoptosis in many cases, by repressing genes such as p53, Bak 1 and PUMA, 12, 29 it has also been shown to downregulate proliferation of various cancer cell lines. [30] [31] [32] Therefore, the role of miR-125b in regulating 2 apparently opposing processes, cell proliferation and apoptosis, allows it to buffer and fine tune the subtle balance between apoptosis and cell cycle regulators in complex cellular responses. In fact, miR-125b has been found to directly target 20 genes in the p53 network, which includes regulators of both apoptosis and cell proliferation. 13 Therefore, the delayed increase of miR-125b in response to UVC irradiation might be part of the complex cellular response to DNA damage which causes a decrease in cell proliferation and increase in programmed cell death if the DNA damage is not repaired. However, exogenous overexpression of miR-125b causes downregulation of p53, and thereby increases cell proliferation as we observe in our experiments. Remarkably, our observations suggest that p53 plays a crucial role in this dual function of miR-125b, as miR-125b overexpression causes a decrease in colony formation when p53 is absent. This is not observed in the cell proliferation assay which is done over a period of 72 hours, but is observed in the colony formation assay which is done over a period of 14 days. This gives rise to the interesting possibility that miR-125b targets p53 and causes increased cell proliferation and reduced apoptosis, thereby acting as an oncogenic miRNA. However, when p53 is lost or repressed over a prolonged period, miR125b targets other regulators of cell proliferation and thereby acts as a tumor suppressor. Thus, the miR-125b-mediated regulation of p53 appears to play an important role in the complex process of maintaining the balance between cell proliferation and apoptosis.
HuR, which undergoes nuclear cytoplasmic translocation in response to UVC irradiation, counteracts the translation repressive effect of miR-125b on p53 mRNA, and thereby maintains p53 expression in response to genotoxic stress even when miR-125b level is high. This allows the cell to undergo p53-mediated cell cycle arrest and apoptosis if the DNA damage repair fails. This growth suppressive and pro-apoptotic effect suggests an anti-oncogenic function of HuR. However, a number of reports have demonstrated the role of HuR in inhibiting apoptosis, enhancing cell proliferation and facilitating invasion and metastasis, suggesting the function of HuR as a pro-oncogenic factor. 33 Therefore our observations also suggest a dual role for HuR as both a pro-oncogenic and anti-oncogenic factor, with the genotoxic stress induced nuclear-cytoplasmic translocation of HuR causing inhibition of cell proliferation and increased apoptosis via enhanced translation of p53 mRNA. Apoptotic stimuli has been shown to shift HuR from being a promoter of cell survival to caspase-mediated programmed cell death, suggesting that apoptotic or genotoxic stimuli might activate the anti-oncogenic function of HuR. 34 Interestingly our observations also suggest that HuR enhance tumor cell colony formation when p53 is knocked down, indicating that the anti-proliferative effect of HuR is dependent on p53.
The interplay between HuR and miR-125b which regulates p53 expression is therefore a new feature of the DNA damage response in cells. Multiple examples of competitive and cooperative interplay between RBPs and miRNAs are now known in cancer.
14 HuR appears to play a major role among RBPs involved in such crosstalk with miRNAs. 35 HuR has been shown to function antagonistically with miRNAs such as miR-122, miR-548c, miR-494, miR-16, miR-331-3p and miR-1192 in response to different stimuli. 15, [36] [37] [38] [39] [40] On the other hand HuR recruits the miRNA let-7 to repress c-Myc expression. 41 HuR also competes with a long non coding RNA, 7SL, to bind with the p53 3 0 UTR and regulate p53 mRNA translation. 18 Recently, we have also shown that HuR may act as a "miRNA sponge" by binding with and sequestering miR-21, thereby reversing the miR-21-mediated translation repression of the tumor suppressor protein PDCD4. 42 Based on our observations in the case of the p53 mRNA, we propose a model in which HuR, on cytopalsmic localization, binds to the 3 binding sites in the p53 3 0 UTR (Fig. 7) . Binding to the site proximal to the miR-125b target site causes the displacement of miR-125b and dissociation of the p53 mRNA from the RISC. Further studies are required to investigate whether the displacement of miR-125b is due to direct steric hindrance or due to a conformational change of the RNA which makes the binding site of miR-125b unavailable. It is interesting to note that the HuR binding site is adjacent to, but non-overlapping with, the miR-125b target site, which is similar to what has been seen in the case of many mRNAs in studies investigating the entire mRNA interactome of HuR. 19, 43 This suggests conformational switching, rather than steric hindrance, as the possible mechanism for the antagonism between HuR and miRNA binding. Recently it has been shown that HuR can prevent the miR-125b-induced recruitment of the PARN deadenylase to the p53 mRNA and its subsequent degradation. 44 However, our study, together with earlier studies, have shown that miR-125b causes translational repression, rather than destabilization, of the p53 mRNA 12 and we have shown that DNA-damage induced nuclear-cytoplasmic translocation of HuR reverses the miR-125b-mediated translation repression by dissociating the p53 mRNA from the RNA-induced silencing complex. Therefore the crosstalk between HuR and miR-125b might take place by different molecular mechanisms in different contexts to regulate the translation repression or degradation of p53 mRNA in order to fine tune p53 expression in response to multiple stress stimuli.
Materials and methods

Plasmid constructs
The full length (1190 nt) p53 3 0 UTR was isolated from human leukocyte RNA by RT-PCR and cloned into pCDNA3.1 (Thermo Fisher Scientific, V790-20) and downstream of firefly luciferase gene in pCDNA3-Fluc vector. Different 3 0 UTR deletion constructs were cloned by PCR from pCDNA3.1-p53 3 0 UTR construct. Double-stranded DNA oligo encoding miR125b was cloned into pSUPER vector (Oligoengine, VEC-PBS-0002) containing the EGFP gene which was transcribed to produce shRNA corresponding to miR-125b. pCI-neo-myc-HuR (gift from S N Bhattacharya, CSIR-IICB) and pET-28b-HuR (gift from S Das, IISc) were used for mammalian and bacterial expression of HuR respectively.
Cell culture, treatment and transfection MCF7 human breast carcinoma cells were maintained in Dulbecco's modified Eagle's Medium (Thermo Fisher Scientific, 12100-046) with 10% FBS (Thermo Fisher Scientific, 10500-064) and 1% Pen-Strep (Thermo Fisher Scientific, 15140-122). Cells were exposed to 10 J/m 2 short wavelength UV (UVC) irradiation in UVC crosslinker (CL 1000, UVP). Cells were transfected with different vectors, siRNAs (siGENOME SMART pool, ELAVL1 (M-003773-04-0005), p53(M-003329-03) and Non Targeting siRNA pool (D-001206-13-05) GE-Dharmacon) and antagomiR against miR-125b (Trilink Biotechnologies, C33-B02A) using Lipofectamine 2000 (Thermo Fisher, 11668019) in DMEM low glucose medium (Thermo Fisher, SH30021.01). DNA amount for transfection was equalised by pGEMT plasmid (Promega, A3600).
Immunoblotting
Cells were lysed in S10 lysis buffer (10 mM HEPES, 15 mM KCl, 1 mM PMSF, 1 mM DTT, 0.1% Triton X100) and centrifuged at 10,000 g for 20 minutes for cytoplasmic lysate preparation. Nuclear and cytosolic extracts were prepared as described previously. 45 Cell lysates were quantified using Bradford reagent (Amresco, E530-1L), resolved on 12% SDS-PAGE and were immunoblotted using anti HuR (3A2, Santa Cruz Biotechnology), p53 (DO-1,Santa Cruz Biotechnology), Ago2 (C34C6, Cell Signaling), Lamin A/C (4C11, Cell Signaling), b-actin (A00730, Genscript) and GAPDH (FL-335, Santa Cruz Biotechnology) antibodies. Chemiluminescent signal was detected using Femtolucent Plus HRP (Geno Biosciences, 786-003).
RNA Immunoprecipitation
A 50% slurry of pre-swelled Protein A Sepharose beads (Sigma Aldrich, P3391) was incubated with anti HuR (Santa Cruz Biotechnology, 3A2), anti Ago2 (Cell Signaling, C34C6) and control IgG (Santa Cruz Biotechnology, sc-2027) overnight at 4 C. 300 mg of precleared lysate was added to the bead-antibody mix and incubated for 4 hrs at 4 C and washed 5 times with NT2 (50 mM Tris Chloride (pH7.4), 150 mM NaCl, 1 mM MgCl 2 , 0.05% NP-40) buffer. RNA was isolated from the immunoprecipitated complexes by Trizol (Thermo Fisher, 15596-018) followed by semiquantitative RT-PCR or qPCR with p53 3 0 UTR specific primers and GAPDH primers as control.
Quantitative PCR
Total cellular RNA was extracted using Trizol and polyadenylated using Poly A polymerase (New England Biolabs, M0276S). cDNA was synthesized from polyadenylated RNA using oligo(dT)-adapter primer by MuMLV reverse transcriptase (Thermo Fisher, 28025-013 ). An adapter-specific primer and microRNA-125b specific primer (miScript primer assay kit, Qiagen, MS00006629) with Power SYBR Green master mix (Applied Biosystems) were used for qPCR reactions in Step One Plus Real time PCR system (Thermo Fisher, 4367659). U6B snRNA and GAPDH primers were used for miRNA and mRNA quantity normalization respectively.
Immunofluorescence
Cells exposed or unexposed to UVC were fixed with 10% PFA at different time points post exposure. After blocking, cells were incubated in anti-HuR antibody (Santa Cruz Biotechnology, 3A2) at 1:500 dilution followed by 1:500 diluted Alexafluor 568-conjugated anti-mouse secondary antibody (Life Technologies, A11004) and DAPI at 0.5 ng/ml (Thermo Fisher, D1306) for nuclear staining. Images were taken in a laser scanning confocal microscope (Zeiss LSM 710) at 40X magnification.
in vitro RNA-protein UV crosslinking assay
P
¡ UTP labeled RNA probes were synthesized by in vitro transcription from linearized plasmid DNA templates using Maxiscript T7 in vitro transcription kit (Thermo Fisher, AM1312). Bacterially expressed and purified 6X His-tagged HuR protein was preincubated in binding buffer (5 mM HEPES, 25 mM KCl, 2 mM MgCl 2 , 2 mM DTT, 0.1 mM EDTA, 1.5 mM ATP, 1 mg/ml tRNA) and then with radiolabelled RNAs of equal specific activity. The RNA-protein complexes were crosslinked with UVC radiation (254 nm) followed by RNase A digestion and were electrophoresed on 12% SDS-PAGE. Gels were dried in gel drier (BioRad) followed by phosphorimaging using Typhoon TrioC variable mode imager (GE healthcare).
Polysome analysis
Transfected cells were treated with Cycloheximide (100 ug/ml) for 30 minutes and lysed with polysome lysis buffer (20 mM Tris-chloride (pH 7.4), 5 mM MgCl 2 , 150 mM NaCl, 1 mM DTT, 0.2 mM PMSF, 0.5% NP40, 1X protease inhibitor, 100 U/ ml RNase Inhibitor) containing cycloheximide. Cytosolic extract was obtained by centrifugation at 10,000 x g for 20 min. 50 OD (260 nm) of cell lysate was loaded on 10-50% (w/v) sucrose gradient followed by centrifugation at 100,000 x g, at 4
C for 4 hours. Fractions were collected using a programmable gradient fractionator (Biocomp Instruments) and absorbance of fractions was measured at 254 nm. RNA was isolated from the fractions by phenol-chloroform extraction and ethanol precipitation.
Cell proliferation, colony formation and apoptosis assays 48 hours post transfection with pSUPER-miR-125b and pCIneo-Myc-HuR vectors, 10 3 cells were seeded and cell proliferation was determined at 24, 48 and 72 hours using the cell growth determination kit, MTT based (Sigma Aldrich, CGD1). Similarly transfected cells, with or without UVC exposure, were seeded in 6 well plates and after 14 d of growth, colonies were counted for GFP expression or stained with crystal violet. For apoptosis assay, 24 hours post transfection cells were exposed to apoptotic stimulus (48 hours serum starvation). Treated cells were stained using Annexin V FITC-Propidium iodide apoptosis detection kit (Sigma Aldrich, APOAF) or AlexaFluor 488-AnnexinV/Dead cell apoptosis kit (Thermo Fisher, V13241) and analyzed using flow cytometry (FACScalibur, BD Biosciences).
Statistical analysis
All graphical data represent mean § standard deviation of at least 3 independent experiments (biological replicates) each done in duplicate (technical replicates).
Ã signifies a p-value 0.05 and ÃÃ signifies a p-value 0.01 (Paired one-tailed Students t test) between controls and samples indicated in the figures.
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